Arizona Regents' Grant Ramps up Study of Valley Fever, Ozone May 15, 2022 A new partnership between the state’s three universities and several state agencies aims to increase understanding of issues like Valley Fever and ozone levels in Arizona – and come up with solutions. U.S. News & World Report
Measuring pollutants that are contaminating indigenous communities May 13, 2022 People living in villages far from the beaten path are experiencing adverse health effects from environmental pollution. Read more Image
Distinguished Advisory Group Supporting CAMI’s Move Forward May 13, 2022 Leaders from across Health Sciences and academia, health care, commerce and government are helping to guide the launch of the new Phoenix-based center. Read more Image
Experts Perplexed Over Number of People Getting Long COVID May 13, 2022 Public health experts are divided over how many people are getting long COVID, a potentially debilitating condition that comes after a patient has recovered from COVID-19. The Hill
New UArizona Health Sciences Center for Advanced Molecular and Immunological Therapies in Phoenix Guided by Diverse Group of Experts May 12, 2022 Health Sciences senior vice president Michael D. Dake, MD, to discuss development of Arizona’s newest biomedical research hub at public forum. Read more Image
Health Sciences Graduates Celebrated With In-Person Events May 12, 2022 After two years of pandemic-related virtual or small in-person ceremonies, 2022 ceremonies were back in a big way. Read more Image
University of Arizona Medical Students Gear Up for Workforce as U.S Hits 1 Million COVID Deaths May 12, 2022 As the nation reaches one million deaths from the Coronavirus, nearly 120 graduates received their diplomas from the College of Medicine – Tucson on Thursday. The graduates will be heading off to start their residencies 63 hospitals in 28 states. Recent graduates are quoted. KOLD-TV (Tucson, AZ)
Cancer Therapy to Order May 12, 2022 Immunotherapy is fast becoming the go-to treatment for many cancers. The University of Arizona Health Sciences expanded a study after releasing positive Phase 1 results in 2020. Five of 10 patients with head and neck cancer experienced a clinical response and two patients showed no detectable disease after treatment. Chemistry & Industry Magazine